Empagliflozin reduces albuminuria-a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Annals of Translational Medicine
Vol/bind	5
Udgave nummer	23
Sider (fra-til)	478
ISSN	2305-5839
DOI	https://doi.org/10.21037/atm.2017.11.02
Status	Udgivet - dec. 2017

Adgang til dokumentet

@article{2273aa2857284529993ddb5753bb0757,

title = "Empagliflozin reduces albuminuria-a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial",

keywords = "Editorial",

author = "Rikke Borg and Frederik Persson",

year = "2017",

month = dec,

doi = "10.21037/atm.2017.11.02",

language = "English",

volume = "5",

pages = "478",

journal = "Annals of Translational Medicine",

issn = "2305-5839",

publisher = "BioMed Central Ltd",

number = "23",

}

TY - JOUR

T1 - Empagliflozin reduces albuminuria-a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

AU - Borg, Rikke

AU - Persson, Frederik

PY - 2017/12

Y1 - 2017/12

KW - Editorial

U2 - 10.21037/atm.2017.11.02

DO - 10.21037/atm.2017.11.02

M3 - Journal article

C2 - 29285511

SN - 2305-5839

VL - 5

SP - 478

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

IS - 23

ER -